Sign in to view content

Predicting Long-term Response to Ranibizumab After Three Injections in Patients With Age-Related Macular Degeneration

Paul Hahn, MD, PhD, FASRS

Video
Published 2020

Related

Episode 176: Journal Club with Drs. Ferhina and M. Ali Khan discussing Preoperative Anti-VEGF, RD after Intravitreal Injection, and Influence of CATT Trial Results
Jayanth Sridhar, MD
Member Podcasts
2019
Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial
Peter A. Campochiaro, MD
Updates from the Field
2021
Defining and Addressing Wet AMD Non-responders
Rishi P. Singh, MD
Updates from the Field
2019

Category: AMD-Neovascular

See more